Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06301997
PHASE2

A Herbal Compound for Psoriasis

Sponsor: Fasa University of Medical Sciences

View on ClinicalTrials.gov

Summary

The goal of this interventional clinical trial study is to compare ZAX.1400.P03 and placebo in Psoriasis patients. The main question it aims to answer is: • Can treatment with ZAX.1400.P03 for 3 weeks improve clinical signs of skin in psoriasis patients? Participants will be divided into two groups of 52 people. One group will use ZAX.1400.P03 topically twice daily for 3 weeks and the other group will use placebo topically twice daily for 3 weeks. Researchers will compare treatment and placebo groups to see if there is any improvement in the clinical signs of skin caused by psoriasis after treatment with ZAX.1400.P03 for 3 weeks.

Official title: Evaluation of Therapeutic Effects of ZAX.1400.P03 a Herbal Compound on Clinical Signs of Skin in Psoriasis Patients

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

104

Start Date

2023-02-01

Completion Date

2025-07-30

Last Updated

2025-03-12

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

ZAX.1400.P03

ZAX.1400.P03, applied twice daily for 3 weeks after enrolment

DRUG

Placebo

Placebo, applied twice daily for 3 weeks after enrolment

Locations (1)

Fasa university of medical sciences

Fasa, Fars, Iran